{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:23:16Z","timestamp":1747207396306,"version":"3.40.5"},"reference-count":195,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["COS"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec><jats:title\/><jats:p>Pyrazolopyrimidines are a privileged class of 5-6 bicyclic systems with three or four nitrogen atoms, including four possible isomeric structures. The significance of this class of compounds is that they can be applied in medical and pharmaceutical fields due to their unlimited biological aptitude, hence it is the basic skeleton of several synthetic drugs. The current review aimed to highlight all the synthetic routes that have been applied to construct the pyrazolo[1,5-a]pyrimidine ring systems up to date. The sections in this study included the synthesis of pyrazolo[1,5- a]pyrimidines by condensation reactions of 5-aminopyrazoles with each of &amp;#946;-diketones, 1,5-diketones, &amp;#946;- ketoaldehydes, &amp;#945;-cyanoaldehydes, &amp;#946;-enaminones, enamines, enaminonitriles, ethers, with unsaturated ketones, unsaturated thiones, unsaturated esters, unsaturated dienones \u201c1,2-allenic\u201d, unsaturated aldehydes, unsaturated imines, and unsaturated nitriles. The routes adopted to synthesize this class of heterocyclic compounds were extended for ring construction from acyclic reagents and multicomponent reactions under catalytic or catalyst-free conditions.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1570179418666210509015108","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T18:05:19Z","timestamp":1620583519000},"page":"547-586","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bicyclic 5-6 Systems: Comprehensive Synthetic Strategies for the Annulations of Pyrazolo[ 1,5-a]pyrimidines"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-3373","authenticated-orcid":true,"given":"Khaled M.","family":"Elattar","sequence":"first","affiliation":[{"name":"Chemistry Department, Faculty of Science, Mansoura University, El-Gomhoria Street, Mansoura, 35516,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-9129","authenticated-orcid":true,"given":"Ahmed","family":"El-Mekabaty","sequence":"additional","affiliation":[{"name":"Chemistry Department, Faculty of Science, Mansoura University, El-Gomhoria Street, Mansoura, 35516,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1016\/j.bmcl.2013.03.113","volume":"23","author":"Engers D.W.","year":"2013","unstructured":"Engers D.W.; Frist A.Y.; Lindsley C.W.; Hong C.C.; Hopkins C.R.; Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett 2013,23(11),3248-3252","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/jhet.482","volume":"47","author":"Ghozlan S.S.","year":"2010","unstructured":"Ghozlan S.S.; Abdelrazek F.M.; Mohamed M.H.; Azmy K.E.; Synthesis of some new pyrazole and pyrazolopyrimidine derivatives. J Heterocycl Chem 2010,47,1379-1385","journal-title":"J Heterocycl Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jhet.377","volume":"47","author":"Frizzo C.P.","year":"2010","unstructured":"Frizzo C.P.; Martins M.P.; Marzari M.B.; Campos P.T.; Claramunt R.M.; Garc&#xED;a M.A.; Sanz D.; Alkorta A.; Elguero J.; Structural studies of 2-methyl-7-substituted pyrazolo[1,5-a]pyrimidines. J Heterocycl Chem 2010,47,1259-1268","journal-title":"J Heterocycl Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1124\/jpet.104.071282","volume":"311","author":"Sullivan S.K.","year":"2004","unstructured":"Sullivan S.K.; Petroski R.E.; Verge G.; Gross R.S.; Foster A.C.; Grigoriadis D.E.; Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor. J Pharmacol Exp Ther 2004,311,537-546","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.bmc.2007.10.079","volume":"16","author":"Hoepping A.","year":"2008","unstructured":"Hoepping A.; Diekers M.; Deuther-Conrad W.; Scheunemann M.; Fischer S.; Hiller A.; Wegner F.; Steinbach J.; Brust P.; Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors. Bioorg Med Chem 2008,16(3),1184-1194","journal-title":"Bioorg Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0960-894X(01)80810-6","volume":"1","author":"Atwal K.S.","year":"1991","unstructured":"Atwal K.S.; Moreland S.; Dihydropyrimidine calcium channel blockers 51: Bicyclic dihydropyrimidines as potent mimics of dihydropyridines. Bioorg Med Chem Lett 1991,1,29-37","journal-title":"Bioorg Med Chem Lett"},{"author":"Xu Y.","key":"ref=7","doi-asserted-by":"publisher","unstructured":"Xu Y.; Brenning B.G.; Kultgen S.G.; Foulks J.M.; Clifford A.; Lai S.; Chan A.; Merx S.; McCullar M.V.; Kanner S.B.; Ho K-K.; Synthesis and biological evaluation of pyrazolo[1,5-a]pyrimidine compounds as potent and selective pim-1 inhibitors. ACS Med. Chem. Lett., 2014, 6(1), 63-67.","DOI":"10.1021\/ml500300c"},{"author":"Tian Y.","key":"ref=7b","doi-asserted-by":"publisher","unstructured":"Tian Y.; Du D.; Rai D.; Wang L.; Liu H.; Zhan P.; De Clercq E.; Pannecouque C.; Liu X.; Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives. Bioorg. Med. Chem., 2014, 22(7), 2052-2059.","DOI":"10.1016\/j.bmc.2014.02.029"},{"key":"ref=7b","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/ml400197u","volume":"4","author":"Dowling J.E.","year":"2013","unstructured":"Dowling J.E.; Alimzhanov M.; Bao L.; Block M.H.; Chuaqui C.; Cooke E.L.; Denz C.R.; Hird A.; Huang S.; Larsen N.A.; Peng B.; Pontz T.W.; Rivard-Costa C.; Saeh J.C.; Thakur K.; Ye Q.; Zhang T.; Lyne P.D.; structure and property based design of pyrazolo[1,5-a]pyrimidine inhibitors of CK2 kinase with activity in vivo. ACS Med Chem Lett 2013,4(8),800-805","journal-title":"ACS Med Chem Lett"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/acsmedchemlett.5b00485","volume":"7","author":"Liu Y.","year":"2016","unstructured":"Liu Y.; Laufer R.; Patel N.K.; Ng G.; Sampson P.B.; Li S.W.; Lang Y.; Feher M.; Brokx R.; Beletskaya I.; Hodgson R.; Plotnikova O.; Awrey D.E.; Qiu W.; Chirgadze N.Y.; Mason J.M.; Wei X.; Lin D.C.; Che Y.; Kiarash R.; Fletcher G.C.; Mak T.W.; Bray M.R.; Pauls H.W.; Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent. ACS Med Chem Lett 2016,7(7),671-675","journal-title":"ACS Med Chem Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejmech.2016.04.068","volume":"119","author":"Zhao M.","year":"2016","unstructured":"Zhao M.; Ren H.; Chang J.; Zhang D.; Yang Y.; He Y.; Qi C.; Zhang H.; Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo. Eur J Med Chem 2016,119,183-196","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejmech.2013.04.029","volume":"64","author":"Al-Adiwish W.M.","year":"2013","unstructured":"Al-Adiwish W.M.; Tahir M.I.M.; Siti-Noor-Adnalizawati A.; Hashim S.F.; Ibrahim N.; Yaacob W.A.; Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c][1,2,4]triazine derivatives from new 5-aminopyrazoles. Eur J Med Chem 2013,64,464-476","journal-title":"Eur J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.1016\/j.bmcl.2009.09.087","volume":"19","author":"Popovici-Muller J.","year":"2009","unstructured":"Popovici-Muller J.; Shipps G.W.; Rosner K.E.; Deng Y.; Wang T.; Curran P.J.; Brown M.A.; Siddiqui M.A.; Cooper A.B.; Duca J.; Cable M.; Girijavallabhan V.; Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase. Bioorg Med Chem Lett 2009,19(22),6331-6336","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1248\/cpb.55.881","volume":"55","author":"Mukaiyama H.","year":"2007","unstructured":"Mukaiyama H.; Nishimura T.; Shiohara H.; Kobayashi S.; Komatsu Y.; Kikuchi S.; Tsuji E.; Kamada N.; Ohnota H.; Kusama H.; Discovery of novel 2-anilinopyrazolo[1,5-a]pyrimidine derivatives as c-Src kinase inhibitors for the treatment of acute ischemic stroke. Chem Pharm Bull (Tokyo) 2007,55(6),881-889","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.bmcl.2006.12.116","volume":"17","author":"Powell D.","year":"2007","unstructured":"Powell D.; Gopalsamy A.; Wang Y.D.; Zhang N.; Miranda M.; McGinnis J.P.; Rabindran S.K.; Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel antiproliferative agents: Exploration of core and headpiece structure-activity relationships. Bioorg Med Chem Lett 2007,17(6),1641-1645","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1016\/j.bmc.2008.02.043","volume":"16","author":"Farag A.M.","year":"2008","unstructured":"Farag A.M.; Mayhoub A.S.; Barakat S.E.; Bayomi A.H.; Synthesis of new N-phenylpyrazole derivatives with potent antimicrobial activity. Bioorg Med Chem 2008,16(8),4569-4578","journal-title":"Bioorg Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/jm0009383","volume":"44","author":"Almansa C.","year":"2001","unstructured":"Almansa C.; de Arriba A.F.; Cavalcanti F.L.; G&#xF3;mez L.A.; Miralles A.; Merlos M.; Garc&#xED;a-Rafanell J.; Forn J.; Synthesis and SAR of a new series of COX-2-selective inhibitors: Pyrazolo[1,5-a]pyrimidines. J Med Chem 2001,44(3),350-361","journal-title":"J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1021\/jm061035y","volume":"50","author":"Zhou H-B.","year":"2007","unstructured":"Zhou H-B.; Sheng S.; Compton D.R.; Kim Y.; Joachimiak A.; Sharma S.; Carlson K.E.; Katzenellenbogen B.S.; Nettles K.W.; Greene G.L.; Katzenellenbogen J.A.; Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. J Med Chem 2007,50(2),399-403","journal-title":"J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1016\/j.bmc.2005.05.015","volume":"13","author":"Selleri S.","year":"2005","unstructured":"Selleri S.; Gratteri P.; Costagli C.; Bonaccini C.; Costanzo A.; Melani F.; Guerrini G.; Ciciani G.; Costa B.; Spinetti F.; Martini C.; Bruni F.; Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: Synthesis, biological evaluation and 3D-QSAR investigation. Bioorg Med Chem 2005,13(16),4821-4834","journal-title":"Bioorg Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1021\/jm7014556","volume":"51","author":"Fookes C.J.R.","year":"2008","unstructured":"Fookes C.J.R.; Pham T.Q.; Mattner F.; Greguric I.; Loc\u2019h C.; Liu X.; Berghofer P.; Shepherd R.; Gregoire M-C.; Katsifis A.; Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem 2008,51(13),3700-3712","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"12179","DOI":"10.1039\/c1cc14587h","volume":"47","author":"Crossley E.L.","year":"2011","unstructured":"Crossley E.L.; Issa F.; Scarf A.M.; Kassiou M.; Rendina L.M.; Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: Exploitation of the translocator protein for the efficient delivery of boron into human glioma cells. Chem Commun (Camb) 2011,47(44),12179-12181","journal-title":"Chem Commun (Camb)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10593-005-0176-6","volume":"41","author":"Danagulyan G.G.","year":"2005","unstructured":"Danagulyan G.G.; Mkrtchyan A.D.; Panosyan G.A.; Recyclization of Condensed Carbethoxypyrimidines Accompanied by Substitution of a Carbon Atom into the Heterocycle. Chem Heterocycl Compd 2005,41(4),485-491","journal-title":"Chem Heterocycl Compd"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jhet.5570400312","volume":"40","author":"Elmaati T.M.A.","year":"2003","unstructured":"Elmaati T.M.A.; Said S.B.; Elenein N.S.A.; Khodeir N.M.; Sofan M.M.; 3\u2010(Phenylhydrazono)\u2010indan\u20101\u2010one and 2\u2010dimethylaminomethylene\u20103\u2010(phenylhydrazono)\u2010indan\u20101\u2010one as useful synthons for the construction of new heterocyclic systems. J Heterocycl Chem 2003,40(3),481-486","journal-title":"J Heterocycl Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3987\/COM-07-11060","volume":"71","author":"Shaaban M.R.","year":"2007","unstructured":"Shaaban M.R.; Saleh T.S.; Farag A.M.; Synthesis and Antimicrobial Evaluation of Novel Pyrazolo[1,5-a]pyrimidine, Triazolo[1,5-a]pyrimidine and Pyrimido[1,2-a]benzimidazole Derivatives. Heterocycles 2007,71(8),1765-1777","journal-title":"Heterocycles"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3998\/ark.5550190.p009.743","volume":"5","author":"Abdelall E.","year":"2016","unstructured":"Abdelall E.; Philoppes J.; Synthesis and cytotoxic activity of new pyrazolo[1,5-a]pyrimidines and determination of pyrimidine regiospecific ring formation with 2D NMR. ARKIVOC 2016,5,210-224","journal-title":"ARKIVOC"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jhet.55704 40212","volume":"44","author":"Baraldi P.G.","year":"2007","unstructured":"Baraldi P.G.; Fruttarolo F.; Tabrizi M.A.; Romagnoli R.; Preti D.; Ongini E.; El-Kashef H.; Carri&#xF3;n M.D.; Borea P.A.; Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon. J Heterocycl Chem 2007,44,355-361","journal-title":"J Heterocycl Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jhet.5570380516","volume":"38","author":"Mustazza C.","year":"2001","unstructured":"Mustazza C.; Rosaria M.; Giudice D.; Borioni A.; Gatta F.; Synthesis of pyrazolo[1,5-a]-1,2,4-triazolo[1,5-a]- and imidazo[1,2-a]pyrimidines related to zaleplon, a new drug for the treatment of insomnia. J Heterocycl Chem 2001,38,1119-1129","journal-title":"J Heterocycl Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1039\/c3ob42445f","volume":"12","author":"Zhang X.","year":"2014","unstructured":"Zhang X.; Song Y.; Gao L.; Guo X.; Fan X.; Highly facile and regio-selective synthesis of pyrazolo[1,5-a]pyrimidines via reactions of 1,2-allenic ketones with aminopyrazoles. Org Biomol Chem 2014,12(13),2099-2107","journal-title":"Org Biomol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/jhet.128","volume":"46","author":"Ghotekar B.K.","year":"2009","unstructured":"Ghotekar B.K.; Jachak M.; Toche R.B.; New one-step synthesis of pyrazolo[1,5-a]pyrimidine and pyrazolo[1,5-a]quinazoline derivatives via multicomponent reactions. J Heterocycl Chem 2009,46,708-713","journal-title":"J Heterocycl Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/jhet.2006","volume":"51","author":"Rote R.V.","year":"2014","unstructured":"Rote R.V.; Shelar D.P.; Jachak M.N.; A convenient synthesis of new pyrazolo[4,3-d]pyrimidines and their fused heterocycles. J Heterocycl Chem 2014,51,815-823","journal-title":"J Heterocycl Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/jhet.1550","volume":"50","author":"Shamroukh A.H.","year":"2013","unstructured":"Shamroukh A.H.; Rashad A.E.; Ali H.S.; Abdel-Megeid F.E.; Some new pyrazole and pyrazolopyrimidines: Synthesis and antimicrobial evaluation. J Heterocycl Chem 2013,50,758-765","journal-title":"J Heterocycl Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1016\/j.bmcl.2012.07.059","volume":"22","year":"2012","unstructured":"Hossein nia, R.; Mamaghani, M.; Tabatabaeian, K.; Shirini, F.; Rassa, M. An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction. Bioorg Med Chem Lett 2012,22(18),5956-5960","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jhet.852","volume":"49","author":"Hussein A.M.","year":"2012","unstructured":"Hussein A.M.; Novel synthesis of some new pyrimido[1,6-a]pyrimidine and pyrazolo[1,5-a]pyrimidine derivatives. J Heterocycl Chem 2012,49,446-451","journal-title":"J Heterocycl Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jhet.724","volume":"49","author":"Masevicius V.","year":"2012","unstructured":"Masevicius V.; Juskenas R.; Tumkevicius S.; Synthesis of novel pyrazolo[3,4-d]pyrimidines peri-fused with 1,4-diazepine, 1,4-thiazepine, and 1,2,4-triazepine rings. J Heterocycl Chem 2012,49,315-320","journal-title":"J Heterocycl Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jhet.5570320149","volume":"32","author":"Bruni F.","year":"1995","unstructured":"Bruni F.; Selleri S.; Costanzo A.; Guerrini G.; Casilli M.L.; Giusti L.; Reactivity of 7\u2010(2\u2010dimethylaminovinyl)pyrazolo[1,5\u2010a]pyrimidines: Synthesis of pyrazolo[1,5\u2010a]pyrido[3,4\u2010e]pyrimidine derivatives as potential benzodiazepine receptor ligands. J Heterocycl Chem 1995,32(1),291-298","journal-title":"J Heterocycl Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1002\/ejoc.201701024","volume":"2017","author":"Jismy B.","year":"2017","unstructured":"Jismy B.; Guillaumet G.; Allouchi H.; Akssira M.; Abarbri M.; Concise and Efficient Access to 5,7-Disubstituted Pyrazolo[1,5-a]pyrimidines by Pd-Catalyzed Sequential Arylation, Alkynylation, and SNAr Reaction. Eur J Org Chem 2017,2017(41),6168-6178","journal-title":"Eur J Org Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"8267","DOI":"10.1016\/j.tet.2014.09.020","volume":"70","author":"Drev M.","year":"2014","unstructured":"Drev M.; Gro\u0161elj U.; Mevec \u0160.; Pu\u0161avec E.; \u0160trekelj J.; Golobic A.; Dahmann G.; Stanovnik B.; Svete J.; Regioselective synthesis of 1- and 4-substituted 7-oxopyrazolo[1,5-a]pyrimidine-3-carboxamides. Tetrahedron 2014,70,8267-8279","journal-title":"Tetrahedron"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/S0040-4039(00)79795-4","volume":"14","author":"Novinson T.","year":"1973","unstructured":"Novinson T.; Robins R.K.; O\u2019Brien D.E.; A new fluorination procedure. Fluorination of 5,7-dimethylpyrazolo[1,5-a]pyrimidine. Tetrahedron Lett 1973,14(34),3149-3150","journal-title":"Tetrahedron Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-1139(00)80313-9","volume":"51","author":"Fabron J.","year":"1991","unstructured":"Fabron J.; Pastor R.; Cambon. A. Synthese de pyrazolo[1,5-a]pyrimidines F-alkylees. J Fluor Chem 1991,51(1),141-148","journal-title":"J Fluor Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molstruc.2009.06.021","volume":"934","author":"Aggarwal R.","year":"2009","unstructured":"Aggarwal R.; Sumran G.; Claramunt R.M.; Sanz D.; Elguero J.; Synthesis and structural characterization of pyrazol-1\u2032-ylpyrazolo[1,5-a]pyrimidines by multinuclear NMR spectroscopy. J Mol Struct 2009,934(1\u20133),96-102","journal-title":"J Mol Struct"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1080\/00397911.2020.1807570","volume":"50","author":"Abdel-Megid M.","year":"2020","unstructured":"Abdel-Megid M.; Part-II: Utilities of active methylene compounds and heterocycles bearing active methyl or having an active methine in the formation of bioactive pyrazoles and pyrazolopyrimidines. Synth Commun 2020,50(23),3563-3591","journal-title":"Synth Commun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1080\/00397911.2019.1604967","volume":"49","author":"Salem M.A.","year":"2019","unstructured":"Salem M.A.; Helal M.H.; Gouda M.A.; Abd EL-Gawad, H. H.; Shehab, M. A. M.; El-Khalafawy, A. Recent synthetic methodologies for pyrazolo[1,5-a]pyrimidine. Synth Commun 2019,49(14),1750-1776","journal-title":"Synth Commun"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2174\/1385272823666190410145238","volume":"23","author":"Al-Azmi A.","year":"2019","unstructured":"Al-Azmi A.; Pyrazolo[1,5-a]pyrimidines: A close look into their synthesis and applications. Curr Org Chem 2019,23(6),721-743","journal-title":"Curr Org Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.fjps.2016.08.004","volume":"2","author":"Ismail N.S.M.","year":"2016","unstructured":"Ismail N.S.M.; Ali G.M.E.; Ibrahim D.A.; Elmetwali A.M.; Medicinal attributes of Pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. Future J Pharm Sci 2016,2(2),60-70","journal-title":"Future J Pharm Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"71827","DOI":"10.1039\/C6RA12364C","volume":"6","author":"Elattar K.M.","year":"2016","unstructured":"Elattar K.M.; Mert B.D.; Recent developments in the chemistry of bicyclic 6-6 systems: Chemistry of pyrido[4,3-d]pyrimidines. RSC Advances 2016,6,71827-71851","journal-title":"RSC Advances"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1080\/00397911.2015.1089577","volume":"45","author":"Fadda A.A.","year":"2015","unstructured":"Fadda A.A.; El-Hadidy S.A.; Elattar K.M.; Advances in 1,8-naphthyridines chemistry. Synth Commun 2015,45(24),2765-2801","journal-title":"Synth Commun"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1080\/00397911.2012.744842","volume":"43","author":"Fadda A.A.","year":"2013","unstructured":"Fadda A.A.; El-Mekabaty A.; Elattar K.M.; Chemistry of enaminonitriles of pyrano[2,3-c]pyrazole and related compounds. Synth Commun 2013,43(20),2685-2719","journal-title":"Synth Commun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/00397911.2016.1166252","volume":"46","author":"Elattar K.M.","year":"2016","unstructured":"Elattar K.M.; Youssef I.; Fadda A.A.; Reactivity of indolizines in organic synthesis. Synth Commun 2016,46,719-744","journal-title":"Synth Commun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/00397911.2016.1211702","volume":"46","author":"Elattar K.M.","year":"2016","unstructured":"Elattar K.M.; Rabie R.; Hammouda M.M.; Recent developments in the chemistry of bicyclic 6-6 systems: Chemistry of pyrido[1,2-c]pyrimidines. Synth Commun 2016,46,1477-1498","journal-title":"Synth Commun"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2174\/1570179416666190704113647","volume":"16","author":"Monier M.","year":"2019","unstructured":"Monier M.; Abdel-Latif D.; El-Mekabaty A.; Mert B.D.; Elattar K.M.; Advances in the Chemistry of 6-6 Bicyclic Systems: Chemistry of Pyrido[3,4- d]pyrimidines. Curr Org Synth 2019,16(6),812-854","journal-title":"Curr Org Synth"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00706-016-1852-1","volume":"148","author":"Elattar K.M.","year":"2017","unstructured":"Elattar K.M.; Rabie R.; Hammouda M.M.; Recent progress in the chemistry of bicyclic 6-6 systems: Chemistry of pyrido[1,2-a]pyrimidines. Monatsh Chem 2017,148,601-627","journal-title":"Monatsh Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/jhet.3727","volume":"56","author":"Monier M.","year":"2019","unstructured":"Monier M.; Abdel-Latif D.; El-Mekabaty A.; Elattar K.M.; Reactivity, and Stereoselectivity of Oxazolopyridines with A Ring-Junction Nitrogen Atom. J Heterocycl Chem 2019,56(12),3172-3196","journal-title":"J Heterocycl Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00397911.2019.1686644","volume":"50","author":"Monier M.","year":"2020","unstructured":"Monier M.; Abdel-Latif D.; El-Mekabaty A.; Elattar K.M.; Recent progress in the chemistry of heterocycles incorporated oxazolo[4,5-b]pyridine and oxazolo[5,4-b]pyridine skeletons. Synth Commun 2020,50(1),1-32","journal-title":"Synth Commun"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1080\/00397911.2019.1643889","volume":"49","author":"Monier M.","year":"2019","unstructured":"Monier M.; El-Mekabaty A.; Abdel-Latif D.; Elattar K.M.; Chemistry of Bicyclic 5-6 Systems: Synthesis of Oxazolo[3,2-a]pyridines and their Salts with A Ring-Junction Nitrogen Atom. Synth Commun 2019,49(20),2591-2629","journal-title":"Synth Commun"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ardp.19853180207","volume":"318","author":"Klein H.J.","year":"1985","unstructured":"Klein H.J.; Trosch&#xFC;tz R.; Roth H.J.; Synthese von 5-Aminopyrazolo[1,5-a]pyrimidin-7(4H)-onen. Arch Pharm (Weinheim) 1985,318(2),135-142","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1002\/cber.19701031029","volume":"103","author":"Reimlinger H.","year":"1970","unstructured":"Reimlinger H.; Peiren M.A.; Mer&#xE9;nyi R.; Synthesen mit heterocyclischen Aminen, I. Reaktionen des 3(5)-Amino-pyrazols mit &#x3B1;,&#x3B2;-unges&#xE4;ttigten Estern. Darstellung und Charakterisierung isomerer Oxo-dihydro-pyrazolo-pyrimidine. Chem Ber 1970,103(10),3252-3265","journal-title":"Chem Ber"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/jhet.5570110330","volume":"11","author":"Alcalde E.","year":"1974","unstructured":"Alcalde E.; De Mendoza J.; Elguero J.; Marino J.; Marquina G.; Almera C.; Elude de la r&#xE9;action du &#x3B2;-aminocrotonitrile et du &#x3B1;-formyl ph&#xE9;nylac&#xE9;tonitrile avec l\u2019hydrazine: Synth&#xE8;se d\u2019amino-7-pyrazolo[1,5-a]pyrimidines. J Heterocycl Chem 1974,11(3),423-429","journal-title":"J Heterocycl Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/jhet.5570120315","volume":"12","author":"Ratajczyk J.D.","year":"1975","unstructured":"Ratajczyk J.D.; Swett L.R.; The cyclocondensation of 5-amino-1,3-dimethylpyrazole with ethyl acetoacetate. Synthesis of isomeric pyrazolopyridones. J Heterocycl Chem 1975,12(3),517-522","journal-title":"J Heterocycl Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/jm00239a004","volume":"18","author":"Novinson T.","year":"1975","unstructured":"Novinson T.; Miller J.P.; Scholten M.; Robins R.K.; Simon L.N.; O\u2019Brien D.E.; Meyer R.B.; Jr. Adenosine cyclic 3\u2032,5\u2032,-monophosphate phosphodiesterasr inhibitors. 2.3-Substituted 5,7-dialkylpyrazolo [1,5-a]pyrimidines. J Med Chem 1975,18(5),460-464","journal-title":"J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/prac.19713130524","volume":"313","author":"Dorn H.","year":"1971","unstructured":"Dorn H.; Zubek A.; &#xDC;ber Pyrazolo[1,5\u2010a]pyrimidine. J Prakt Chem 1971,313(5),969-976","journal-title":"J Prakt Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1021\/jm00237a021","volume":"18","author":"Senga K.","year":"1975","unstructured":"Senga K.; Novinson T.; Springer R.H.; Rao R.P.; O\u2019Brien D.E.; Robins R.K.; Wilson H.R.; Synthesis and antitrichomonal activity of certain pyrazolo (1,5-a) pyrimidines. J Med Chem 1975,18(3),312-314","journal-title":"J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1021\/jm00224a017","volume":"19","author":"Springer R.H.","year":"1976","unstructured":"Springer R.H.; Dimmitt M.K.; Novinson T.; O\u2019Brien D.E.; Robins R.K.; Simon L.N.; Miller J.P.; Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines. J Med Chem 1976,19(2),291-296","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1021\/jm00213a014","volume":"20","author":"Kirkpatrick W.E.","year":"1977","unstructured":"Kirkpatrick W.E.; Okabe T.; Hillyard I.W.; Robins R.K.; Dren A.T.; Novinson T.; 3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates. J Med Chem 1977,20(3),386-393","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1139\/v75-016","volume":"53","author":"Lynch B.M.","year":"1975","unstructured":"Lynch B.M.; Khan M.A.; Sharma S.C.; Teo H.C.; Pyrazolo[1,5-a]pyrimidine: Synthesis and Regiospecific Electrophilic Substitution in the Pyrazole and\/or Pyrimidine Rings. Can J Chem 1975,53,119-124 https:\/\/cdnsciencepub.com\/doi\/pdf\/10.1139\/v75-016","journal-title":"Can J Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1248\/cpb.10.612","volume":"10","author":"Makisumi Y.","year":"1962","unstructured":"Makisumi Y.; Studies on the Azaindolizine Compounds. X. Synthesis of 5,7-Disubstituted Pyrazolo[1,5-a]pyrimidines. Chem Pharm Bull (Tokyo) 1962,10(7),612-620","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1021\/jm00212a021","volume":"20","author":"Novinson T.","year":"1977","unstructured":"Novinson T.; Robins R.K.; Matthews T.R.; Synthesis and antifungal properties of certain 7-alkylaminopyrazolo[1,5-a]pyrimidines. J Med Chem 1977,20(2),296-299","journal-title":"J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/jhet.5570210402","volume":"21","author":"Hammouda H.A.","year":"1984","unstructured":"Hammouda H.A.; El-Barbary A.A.; Sharaf M.A.F.; Reactions with 5\u2010aminopyrazoles. I. Synthesis of halogen\u2010containing fused pyrazoles. J Heterocycl Chem 1984,21(4),945-947","journal-title":"J Heterocycl Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/je00042a048","volume":"30","author":"Sadek K.U.","year":"1985","unstructured":"Sadek K.U.; Selim M.A.; El-Maghraby M.A.; Reactions with Heterocyclic Amidines: Synthesis of Several New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[1,5-c]-as-triazines. J Chem Eng Data 1985,30(4),514-515","journal-title":"J Chem Eng Data"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1021\/jm00137a023","volume":"24","author":"Senga K.","year":"1981","unstructured":"Senga K.; Novinson T.; Wilson H.R.; Robins R.K.; Synthesis and antischistosomal activity of certain pyrazolo[1,5-a]pyrimidines. J Med Chem 1981,24(5),610-613","journal-title":"J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1021\/jo981423a","volume":"64","author":"Shiota T.","year":"1999","unstructured":"Shiota T.; Yamamori T.; Regioselective Reactions of Organozinc Reagents with 2,4-Dichloroquinoline and 5,7-Dichloropyrazolo[1,5-a]pyrimidine. J Org Chem 1999,64(2),453-457","journal-title":"J Org Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/jm00345a009","volume":"25","author":"Springer R.H.","year":"1982","unstructured":"Springer R.H.; Scholten M.B.; O\u2019Brien D.E.; Novinson T.; Miller J.P.; Robins R.K.; Synthesis and enzymic activity of 6-carbethoxy- and 6-ethoxy-3,7-disubstituted-pyrazolo[1,5-a]pyrimidines and related derivatives as adenosine cyclic 3\u2032, 5\u2032-phosphate phosphodiesterase inhibitors. J Med Chem 1982,25(3),235-242","journal-title":"J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/BF00799032","volume":"114","author":"Khan M.A.","year":"1983","unstructured":"Khan M.A.; Rolim A.M.C.; Fused pyrazolopyrimidines II. Thieno[3\u2033,2\u2033:5\u2032,6\u2032]-pyrido[4\u2032,3\u2032:3,4]pyrazolo[1,5-a]pyrimidines. Monatsh Chem 1983,114,1079-1085","journal-title":"Monatsh Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/BF02253106","volume":"33","author":"Makarov V.A.","year":"1997","unstructured":"Makarov V.A.; Anisimova O.S.; Granik V.G.; Reaction of 3,5-diamino-4-nitropyrazole with electrophilic reagents. Chem Heterocycl Compd 1997,33(3),276-281","journal-title":"Chem Heterocycl Compd"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF02291935","volume":"33","author":"Makarov V.A.","year":"1997","unstructured":"Makarov V.A.; Soloveva N.P.; Granlk V.G.; Synthesis and NMR spectroscopic study of derivatives of pyrazolo[1,5-a]pyrimidines. Chem Heterocycl Compd 1997,33(5),535-542","journal-title":"Chem Heterocycl Compd"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1023\/A:1019517414682","volume":"38","author":"Danagulyan G.G.","year":"2002","unstructured":"Danagulyan G.G.; Panosyan G.A.; Boyakhchyan A.P.; Synthesis of n-alkylated derivatives of pyrazolo[1,5-a]pyrimidine and their reaction with methylamine. Chem Heterocycl Compd 2002,38(5),581-585","journal-title":"Chem Heterocycl Compd"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1021\/jm049631k","volume":"47","author":"Compton D.R.","year":"2004","unstructured":"Compton D.R.; Sheng S.; Carlson K.E.; Rebacz N.A.; Lee I.Y.; Katzenellenbogen B.S.; Katzenellenbogen J.A.; Pyrazolo[1,5-a]pyrimidines: Estrogen receptor ligands possessing estrogen receptor &#x3B2; antagonist activity. J Med Chem 2004,47(24),5872-5893","journal-title":"J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1021\/jm701397k","volume":"51","author":"Frey R.R.","year":"2008","unstructured":"Frey R.R.; Curtin M.L.; Albert D.H.; Glaser K.B.; Pease L.J.; Soni N.B.; Bouska J.J.; Reuter D.; Stewart K.D.; Marcotte P.; Bukofzer G.; Li J.; Davidsen S.K.; Michaelides M.R.; 7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors. J Med Chem 2008,51(13),3777-3787","journal-title":"J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1134\/S1070428007030281","volume":"43","author":"Emelina E.E.","year":"2007","unstructured":"Emelina E.E.; Petrov A.A.; Firsov A.V.; &#x3B1;-Aminoazoles in syntheses of heterocycles. 3(5)-Aminopyrazole-4-carbonitriles in the synthesis of pyrazolo[1,5-&#x3B1;]pyrimidines. Russ J Org Chem 2007,43,471-473","journal-title":"Russ J Org Chem"},{"key":"ref=77","first-page":"1027","volume":"36","author":"Petrov A.A.","year":"2000","unstructured":"Petrov A.A.; Emelina E.E.; Firsov A.V.; &#x3B1;-Aminoazoles in the synthesis of heterocycles. Part I. Synthesis of regioisomeric 5-methyl-2,7-diphenyl- and 7-methyl-2,5-diphenylpyrazolo[1,5-a]pyrimidines. Russ J Org Chem 2000,36(7),1027-1032","journal-title":"Russ J Org Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1134\/S1070428008020139","volume":"44","author":"Petrov A.A.","year":"2008","unstructured":"Petrov A.A.; Emelina E.E.; Selivanov S.I.; &#x3B1;-Aminoazoles in Synthesis of Heterocycles: IV. Regiodirection of 3(5)-Amino-5(3)-methylpyrazole Reaction with Hexafluoroacetylacetone. Russ J Org Chem 2008,44(2),263-270","journal-title":"Russ J Org Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1134\/S1070428009090139","volume":"45","author":"Petrov A.A.","year":"2009","unstructured":"Petrov A.A.; Kasatochkin A.N.; Emelina E.E.; &#x3B1;-Amino azoles in the synthesis of heterocycles: VI. Synthesis and structure of cycloalkane-annulated pyrazolo[1,5-a]pyrimidines. Russ J Org Chem 2009,45(9),1390-1401","journal-title":"Russ J Org Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1023\/A:1012417816375","volume":"37","author":"Emelina E.E.","year":"2001","unstructured":"Emelina E.E.; Petrov A.A.; Firsov A.V.; Aminoazoles in Heterocycles Synthesis: II. Trifluoromethyl-containing diketones in the synthesis of pyrazolo[1,5-a]pyrimidines. Russ J Org Chem 2001,37,852-858","journal-title":"Russ J Org Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1134\/S1070428012080131","volume":"48","author":"Petrov A.A.","year":"2012","unstructured":"Petrov A.A.; Kasatochkin A.N.; Emelina E.E.; Study of Regioselectivity of Reactions between 3(5)-Aminopyrazoles and 2-Acetylcycloalkanones. Russ J Org Chem 2012,48(8),1111-1120","journal-title":"Russ J Org Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1023\/B:RUJO.0000010564.39518.5e","volume":"39","author":"Petrova O.V.","year":"2003","unstructured":"Petrova O.V.; Sobenina L.N.; Demenev A.P.; Synthesis of Functionalized 2-(2-Pyrrolyl)pyrazolo[1,5-a]pyrimidines. Russ J Org Chem 2003,39,1471-1476","journal-title":"Russ J Org Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/cc049855o","volume":"7","author":"Dalinger I.L.","year":"2005","unstructured":"Dalinger I.L.; Vatsadse I.A.; Shevelev S.A.; Ivachtchenko A.V.; Liquid-phase synthesis of combinatorial libraries based on 7-trifluoromethyl-substituted pyrazolo[1,5-a]pyrimidine scaffold. J Comb Chem 2005,7(2),236-245","journal-title":"J Comb Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1021\/jm100350r","volume":"53","author":"Ivachtchenko A.V.","year":"2010","unstructured":"Ivachtchenko A.V.; Dmitriev D.E.; Golovina E.S.; Kadieva M.G.; Koryakova A.G.; Kysil V.M.; Mitkin O.D.; Okun I.M.; Tkachenko S.E.; Vorobiev A.A.; (3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and selective antagonists of the serotonin 5-HT6 receptor. J Med Chem 2010,53(14),5186-5196","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1021\/jm201079g","volume":"54","author":"Ivachtchenko A.V.","year":"2011","unstructured":"Ivachtchenko A.V.; Golovina E.S.; Kadieva M.G.; Kysil V.M.; Mitkin O.D.; Tkachenko S.E.; Okun I.M.; Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists. J Med Chem 2011,54(23),8161-8173","journal-title":"J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1021\/jm300063b","volume":"55","author":"Patnaik S.","year":"2012","unstructured":"Patnaik S.; Zheng W.; Choi J.H.; Motabar O.; Southall N.; Westbroek W.; Lea W.A.; Velayati A.; Goldin E.; Sidransky E.; Leister W.; Marugan J.J.; Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase. J Med Chem 2012,55(12),5734-5748","journal-title":"J Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1021\/jm201152u","volume":"55","author":"Gege C.","year":"2012","unstructured":"Gege C.; Bao B.; Bluhm H.; Boer J.; Gallagher B.M.; Korniski B.; Powers T.S.; Steeneck C.; Taveras A.G.; Baragi V.M.; Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis. J Med Chem 2012,55(2),709-716","journal-title":"J Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1021\/jm040058e","volume":"47","author":"Chen C.","year":"2004","unstructured":"Chen C.; Wilcoxen K.M.; Huang C.Q.; Xie Y-F.; McCarthy J.R.; Webb T.R.; Zhu Y-F.; Saunders J.; Liu X-J.; Chen T-K.; Bozigian H.; Grigoriadis D.E.; Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775\/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. J Med Chem 2004,47(19),4787-4798","journal-title":"J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/00397910903020783","volume":"40","author":"El-Essawy F.A.","year":"2010","unstructured":"El-Essawy F.A.; Synthesis of new pyrido[2\u2032,3\u2032:3,4]pyrazolo[1,5-a]pyrimi-dines and their use in the preparation of tetraheterocyclic systems. Synth Commun 2010,40(6),877-887","journal-title":"Synth Commun"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1021\/jm300411k","volume":"55","author":"Kosugi T.","year":"2012","unstructured":"Kosugi T.; Mitchell D.R.; Fujino A.; Imai M.; Kambe M.; Kobayashi S.; Makino H.; Matsueda Y.; Oue Y.; Komatsu K.; Imaizumi K.; Sakai Y.; Sugiura S.; Takenouchi O.; Unoki G.; Yamakoshi Y.; Cunliffe V.; Frearson J.; Gordon R.; Harris C.J.; Kalloo-Hosein H.; Le J.; Patel G.; Simpson D.J.; Sherborne B.; Thomas P.S.; Suzuki N.; Takimoto-Kamimura M.; Kataoka K.; Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: Discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach. J Med Chem 2012,55(15),6700-6715","journal-title":"J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5923\/j.ajoc.20120206.05","volume":"2","author":"Sayed S.M.","year":"2012","unstructured":"Sayed S.M.; Khalil M.A.; Raslan M.A.; A Facile synthesis of new 3-(1-methyl benzimidazol-2-yl) pyrazolopyrimidine and pyrimido[2,1-b][1,3]benzothiazole derivatives of potential biosignificant interest. Am J Org Chem 2012,2(6),151-160","journal-title":"Am J Org Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1021\/acs.jmedchem.5b00932","volume":"58","author":"Damont A.","year":"2015","unstructured":"Damont A.; M&#xE9;dran-Navarrete V.; Cacheux F.; Kuhnast B.; Pottier G.; Bernards N.; Marguet F.; Puech F.; Boisgard R.; Doll&#xE9; F.; Novel pyrazolo[1,5-a]pyrimidines as translocator protein 18 kDa (TSPO) ligands: synthesis, in vitro biological evaluation, [(18)F]-labeling, and in vivo neuroinflammation PET images. J Med Chem 2015,58(18),7449-7464","journal-title":"J Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.bmcl.2016.02.072","volume":"26","author":"Kamal A.","year":"2016","unstructured":"Kamal A.; Faazil S.; Hussaini S.M.A.; Ramaiah M.J.; Balakrishna M.; Patel N.; Pushpavalli S.N.C.V.L.; Pal-Bhadra M.; Synthesis and mechanistic aspects of 2-anilinonicotinyl-pyrazolo[1,5-a]pyrimidine conjugates that regulate cell proliferation in MCF-7 cells via estrogen signaling. Bioorg Med Chem Lett 2016,26(8),2077-2083","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1021\/acsmedchemlett.7b00317","volume":"8","author":"Abe M.","year":"2017","unstructured":"Abe M.; Seto M.; Gogliotti R.G.; Loch M.T.; Bollinger K.A.; Chang S.; Engelberg E.M.; Luscombe V.B.; Harp J.M.; Bubser M.; Engers D.W.; Jones C.K.; Rodriguez A.L.; Blobaum A.L.; Conn P.J.; Niswender C.M.; Lindsley C.W.; Discovery of VU6005649, a CNS Penetrant mGlu7\/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines. ACS Med Chem Lett 2017,8(10),1110-1115","journal-title":"ACS Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1016\/j.bmc.2019.07.036","volume":"27","author":"Hieu Tran V.","year":"2019","unstructured":"Hieu Tran V.; Park H.; Park J.; Kwon Y-D.; Kang S.; Ho Jung J.; Chang K-A.; Chul Lee B.; Lee S-Y.; Kang S.; Kim H-K.; Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide. Bioorg Med Chem 2019,27(18),4069-4080","journal-title":"Bioorg Med Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejmech.2018.09.069","volume":"159","author":"Kwon Y-D.","year":"2018","unstructured":"Kwon Y-D.; Kang S.; Park H.; Cheong I.K.; Chang K-A.; Lee S.Y.; Jung J.H.; Lee B.C.; Lim S.T.; Kim H.K.; Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET. Eur J Med Chem 2018,159,292-306","journal-title":"Eur J Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.bmcl.2016.06.041","volume":"26","author":"Li J.","year":"2016","unstructured":"Li J.; Schulte M.L.; Nickels M.L.; Manning H.C.; New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO. Bioorg Med Chem Lett 2016,26(15),3472-3477","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.molstruc.2016.07.043","volume":"1125","author":"Zahdifar M.","year":"2016","unstructured":"Zahdifar M.; Razavi R.; Sheibani H.; Reaction of (chloro carbonyl) phenyl ketene with 5-amino pyrazolones: Synthesis, characterization, and theoretical studies of 7-hydroxy-6-phenyl-3-(phenyldiazenyl)pyrazolo[1,5-a]pyrimidine-2,5(1H,4H)-dione derivatives. J Mol Struct 2016,1125,730-735","journal-title":"J Mol Struct"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"25104","DOI":"10.1021\/acsomega.0c02675","volume":"5","author":"Hebishy A.M.S.","year":"2020","unstructured":"Hebishy A.M.S.; Salama H.T.; Elgemeie G.H.; New route to the synthesis of benzamide-based 5-aminopyrazoles and their fused heterocycles showing remarkable antiavian influenza virus activity. ACS Omega 2020,5(39),25104-25112","journal-title":"ACS Omega"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bmcl.2015.11.013","volume":"26","author":"Raheem I.T.","year":"2016","unstructured":"Raheem I.T.; Schreier J.D.; Fuerst J.; Gantert L.; Hostetler E.D.; Huszar S.; Joshi A.; Kandebo M.; Kim S.H.; Li J.; Ma B.; McGaughey G.; Sharma S.; Shipe W.D.; Uslaner J.; Vandeveer G.H.; Yan Y.; Renger J.J.; Smith S.M.; Coleman P.J.; Cox C.D.; Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorg Med Chem Lett 2016,26(1),126-132","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1039\/C7MD00193B","volume":"8","author":"Bagul C.","year":"2017","unstructured":"Bagul C.; Rao G.K.; Makani V.K.K.; Tamboli J.R.; Pal-Bhadra M.; Kamal A.; Synthesis and biological evaluation of chalcone-linked pyrazolo[1,5-a]pyrimidines as potential anticancer agents. MedChemComm 2017,8(9),1810-1816","journal-title":"MedChemComm"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.bmcl.2013.03.129","volume":"23","author":"Kamal A.","year":"2013","unstructured":"Kamal A.; Tamboli J.R.; Nayak V.L.; Adil S.F.; Vishnuvardhan M.V.; Ramakrishna S.; Synthesis of pyrazolo[1,5-a]pyrimidine linked aminobenzothiazole conjugates as potential anticancer agents. Bioorg Med Chem Lett 2013,23(11),3208-3215","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cmdc.201200205","volume":"7","author":"Kamal A.","year":"2012","unstructured":"Kamal A.; Tamboli J.R.; Ramaiah M.J.; Adil S.F.; Koteswara Rao G.; Viswanath A.; Mallareddy A.; Pushpavalli S.N.; Pal-Bhadra M.; Anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates as p53 activators in cervical cancer cells. ChemMedChem 2012,7(8),1453-1464","journal-title":"ChemMedChem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1021\/jm5017768","volume":"58","author":"Mackman R.L.","year":"2015","unstructured":"Mackman R.L.; Sangi M.; Sperandio D.; Parrish J.P.; Eisenberg E.; Perron M.; Hui H.; Zhang L.; Siegel D.; Yang H.; Saunders O.; Boojamra C.; Lee G.; Samuel D.; Babaoglu K.; Carey A.; Gilbert B.E.; Piedra P.A.; Strickley R.; Iwata Q.; Hayes J.; Stray K.; Kinkade A.; Theodore D.; Jordan R.; Desai M.; Cihlar T.; Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study. J Med Chem 2015,58(4),1630-1643","journal-title":"J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1021\/jo062120g","volume":"72","author":"Gavrin L.K.","year":"2007","unstructured":"Gavrin L.K.; Lee A.; Provencher B.A.; Massefski W.W.; Huhn S.D.; Ciszewski G.M.; Cole D.C.; McKew J.C.; Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomers. J Org Chem 2007,72(3),1043-1046","journal-title":"J Org Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejmech.2016.09.073","volume":"126","author":"Azeredo L.F.S.P.","year":"2017","unstructured":"Azeredo L.F.S.P.; Coutinho J.P.; Jabor V.A.P.; Feliciano P.R.; Nonato M.C.; Kaiser C.R.; Menezes C.M.S.; Hammes A.S.O.; Caffarena E.R.; Hoelz L.V.B.; de Souza N.B.; Pereira G.A.N.; Cer&#xE1;volo I.P.; Krettli A.U.; Boechat N.; Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors. Eur J Med Chem 2017,126,72-83","journal-title":"Eur J Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11030-018-9865-9","volume":"23","author":"Fayed E.A.","year":"2019","unstructured":"Fayed E.A.; Eissa S.I.; Bayoumi A.H.; Gohar N.A.; Mehany A.B.M.; Ammar Y.A.; Design, synthesis, cytotoxicity and molecular modeling studies of some novel fluorinated pyrazole-based heterocycles as anticancer and apoptosis-inducing agents. Mol Divers 2019,23(1),165-181","journal-title":"Mol Divers"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1007\/s00044-017-1990-y","volume":"26","author":"Hassan A.S.","year":"2017","unstructured":"Hassan A.S.; Masoud D.M.; Sroor F.M.; Askar A.A.; Synthesis and biological evaluation of pyrazolo[1,5-a]pyrimidine-3-carboxamide as antimicrobial agents. Med Chem Res 2017,26,2909-2919","journal-title":"Med Chem Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3797\/scipharm.1211-07","volume":"81","author":"Hafez T.S.","year":"2013","unstructured":"Hafez T.S.; Osman S.A.; Yosef H.A.A.; El-All A.S.; Hassan A.S.; El-Sawy A.A.; Abdallah M.M.; Youns M.; Synthesis, structural elucidation, and in vitro antitumor activities of some pyrazolopyrimidines and schiff bases derived from 5-Amino-3-(arylamino)-1H-pyrazole-4-carboxamides. Sci Pharm 2013,81(2),339-357","journal-title":"Sci Pharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1016\/j.bmc.2019.06.021","volume":"27","author":"Koizumi Y.","year":"2019","unstructured":"Koizumi Y.; Tanaka Y.; Matsumura T.; Kadoh Y.; Miyoshi H.; Hongu M.; Takedomi K.; Kotera J.; Sasaki T.; Taniguchi H.; Watanabe Y.; Takakuwa M.; Kojima K.; Baba N.; Nakamura I.; Kawanishi E.; Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety. Bioorg Med Chem 2019,27(15),3440-3450","journal-title":"Bioorg Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10593-020-02652-1","volume":"56","author":"Burgart Y.V.","year":"2020","unstructured":"Burgart Y.V.; Elkina N.A.; Shchegolkov E.V.; Synthesis of Biologically Active 6-(Tolylhydrazinylidene)Pyrazolo. 1,5-a Pyrimidinones Chem Heterocycl Compd 2020,56,199-207","journal-title":"1,5-a Pyrimidinones Chem Heterocycl Compd"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1021\/acs.jmedchem.9b01681","volume":"63","author":"Li G.","year":"2020","unstructured":"Li G.; Meanwell N.A.; Krystal M.R.; Langley D.R.; Naidu B.N.; Sivaprakasam P.; Lewis H.; Kish K.; Khan J.A.; Ng A.; Trainor G.L.; Cianci C.; Dicker I.B.; Walker M.A.; Lin Z.; Protack T.; Discotto L.; Jenkins S.; Gerritz S.W.; Pendri A.; Discovery and optimization of novel pyrazolopyrimidines as potent and orally bioavailable allosteric HIV-1 integrase inhibitors. J Med Chem 2020,63(5),2620-2637","journal-title":"J Med Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1021\/acs.jmedchem.5b00313","volume":"58","author":"Bertrand S.M.","year":"2015","unstructured":"Bertrand S.M.; Ancellin N.; Beaufils B.; Bingham R.P.; Borthwick J.A.; Boullay A-B.; Boursier E.; Carter P.S.; Chung C.W.; Churcher I.; Dodic N.; Fouchet M-H.; Fournier C.; Francis P.L.; Gummer L.A.; Herry K.; Hobbs A.; Hobbs C.I.; Homes P.; Jamieson C.; Nicodeme E.; Pickett S.D.; Reid I.H.; Simpson G.L.; Sloan L.A.; Smith S.E.; Somers D.O.; Spitzfaden C.; Suckling C.J.; Valko K.; Washio Y.; Young R.J.; The discovery of in vivo active mitochondrial branched-chain aminotransferase (BCATm) inhibitors by hybridizing fragment and HTS Hits. J Med Chem 2015,58(18),7140-7163","journal-title":"J Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","DOI":"10.1039\/C0CC02566F","author":"Murakami M.","unstructured":"Murakami M.; Matsuda T.; Metal-catalysed cleavage of carbon-carbon bonds Chem Commun (Camb), 2011, 47(4), 1100-1105","journal-title":"Metal-catalysed cleavage of carbon-carbon bonds Chem Commun (Camb), 2011, 47(4), 1100-1105"},{"key":"ref=7b","doi-asserted-by":"publisher","DOI":"10.1039\/B702940N","author":"Tobisu M.","unstructured":"Tobisu M.; Chatani N.; Catalytic reactions involving the cleavage of carbon-cyano and carbon-carbon triple bondsChem Soc Rev, 2008, 37(2), 300-307","journal-title":"Catalytic reactions involving the cleavage of carbon-cyano and carbon-carbon triple bondsChem Soc Rev, 2008, 37(2), 300-307"},{"key":"ref=7b","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1039\/B308864M","volume":"33","author":"Jun C-H.","year":"2004","unstructured":"Jun C-H.; Transition metal-catalyzed carbon-carbon bond activation. Chem Soc Rev 2004,33(9),610-618","journal-title":"Chem Soc Rev"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1021\/acs.joc.5b00933","volume":"80","author":"Saikia P.","year":"2015","unstructured":"Saikia P.; Gogoi S.; Boruah R.C.; Carbon-Carbon Bond Cleavage Reaction: Synthesis of Multisubstituted Pyrazolo[1,5-a]pyrimidines. J Org Chem 2015,80(13),6885-6889","journal-title":"J Org Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s007060050025","volume":"131","author":"Elgemeie G.","year":"2000","unstructured":"Elgemeie G.; Metwally N.; Synthesis of structurally related purines: benzimidazo[1,2-a]pyridines, benzimidazo[1,2-c]pyrimidines, and pyrazolo[1,5-a]pyrimidines. Monatsh Chem 2000,131,779-785","journal-title":"Monatsh Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1023\/A:1015420130033","volume":"51","author":"Filyakova V.I.","year":"2002","unstructured":"Filyakova V.I.; Kuznetsova O.A.; Ulomskii E.N.; Synthesis of (7-polyfluoroalkyl)pyrazolo[1,5-a]pyrimidines based on lithium fluorine-containing &#x3B2;-diketonates. Russ Chem Bull 2002,51,332-336","journal-title":"Russ Chem Bull"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bmcl.2009.12.070","volume":"20","author":"Kim I.","year":"2010","unstructured":"Kim I.; Song J.H.; Park C.M.; Jeong J.W.; Kim H.R.; Ha J.R.; No Z.; Hyun Y.L.; Cho Y.S.; Sook Kang N.; Jeon D.J.; Design, synthesis, and evaluation of 2-aryl-7-(3\u2032,4\u2032-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidines as novel PDE-4 inhibitors. Bioorg Med Chem Lett 2010,20(3),922-926","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.bmc.2017.02.013","volume":"25","author":"Guerrini G.","year":"2017","unstructured":"Guerrini G.; Ciciani G.; Daniele S.; Di Cesare Mannelli L.; Ghelardini C.; Martini C.; Selleri S.; Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands. Bioorg Med Chem 2017,25(6),1901-1906","journal-title":"Bioorg Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/S0968-0896(99)00232-1","volume":"7","author":"Selleri S.","year":"1999","unstructured":"Selleri S.; Bruni F.; Costagli C.; Costanzo A.; Guerrini G.; Ciciani G.; Costa B.; Martini C.; Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. Part 1: Study of the structural features for BZR recognition. Bioorg Med Chem 1999,7(12),2705-2711","journal-title":"Bioorg Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2147\/DDDT.S159310","volume":"12","author":"Abdallah A.E.M.","year":"2018","unstructured":"Abdallah A.E.M.; Elgemeie G.H.; Design, synthesis, docking, and antimicrobial evaluation of some novel pyrazolo[1,5-a] pyrimidines and their corresponding cycloalkane ring-fused derivatives as purine analogs. Drug Des Devel Ther 2018,12,1785-1798","journal-title":"Drug Des Devel Ther"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10870-005-3475-y","volume":"35","author":"Li M.","year":"2005","unstructured":"Li M.; Wang S.; Wen L.; Zhang X.; Ke Z.; Synthesis, bioactivities, and X-ray structure analysis of 2-cyano-5-methylpyrazolo[1,5-a]pyrimidine. J Chem Crystallogr 2005,35(9),667-671","journal-title":"J Chem Crystallogr"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1016\/j.bmcl.2009.03.129","volume":"19","author":"Gopalsamy A.","year":"2009","unstructured":"Gopalsamy A.; Ciszewski G.; Hu Y.; Lee F.; Feldberg L.; Frommer E.; Kim S.; Collins K.; Wojciechowicz D.; Mallon R.; Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors. Bioorg Med Chem Lett 2009,19(10),2735-2738","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s10593-008-0053-1","volume":"44","author":"Rao V.R.","year":"2008","unstructured":"Rao V.R.; Reddy V.R.; Synthesis of some new types of 3-coumarinyl-substituted pyrazolopyrimidines and imidazothiazoles. Chem Heterocycl Compd 2008,44,360-365","journal-title":"Chem Heterocycl Compd"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molcata.2011.11.015","volume":"353","author":"Mokhtar M.","year":"2012","unstructured":"Mokhtar M.; Saleh T.S.; Basahel S.N.; Mg-Al hydrotalcites as efficient catalysts for aza-Michael addition reaction: A green protocol. J Mol Catal Chem 2012,353,122-131","journal-title":"J Mol Catal Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/00397911.2011.616639","volume":"43","author":"Abdelhamid A.O.","year":"2013","unstructured":"Abdelhamid A.O.; Fahmi A.A.; Halim K.N.M.; Design and synthesis of some new pyrazolo[1,5-a]pyrimidines, pyrazolo[5,1-c]triazines, pyrazolo[3,4-d]pyridazines, and isoxazolo[3,4-d]pyridazines containing the pyrazole moiety. Synth Commun 2013,43(8),1101-1126","journal-title":"Synth Commun"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00706-015-1638-x","volume":"147","author":"Kaping S.","year":"2016","unstructured":"Kaping S.; Kalita U.; Sunn M.; Singha L.I.; Vishwakarma J.N.; A facile, regioselective synthesis of pyrazolo[1,5-a]pyrimidine analogs in the presence of KHSO4 in aqueous media assisted by ultrasound and their anti-inflammatory and anti-cancer activities. Monatsh Chem 2016,147,1257-1276","journal-title":"Monatsh Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11030-015-9639-6","volume":"20","author":"Kaping S.","year":"2016","unstructured":"Kaping S.; Boiss I.; Singha L.I.; Helissey P.; Vishwakarma J.N.; A facile, regioselective synthesis of novel 3-(N-phenylcarboxamide)pyrazolo[1,5-a]pyrimidine analogs in the presence of KHSO4 in aqueous media assisted by ultrasound and their antibacterial activities. Mol Divers 2016,20(2),379-390","journal-title":"Mol Divers"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00044-016-1770-0","volume":"26","author":"Kumar A.K.A.","year":"2017","unstructured":"Kumar A.K.A.; Bodke Y.D.; Lakra P.S.; Sambasivam G.; Bhat K.G.; Design, synthesis and anticancer evaluation of a novel series of pyrazolo[1,5-a]pyrimidine substituted diamide derivatives. Med Chem Res 2017,26,714-744","journal-title":"Med Chem Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/molecules23061249","volume":"23","author":"El-Naggar M.","year":"2018","unstructured":"El-Naggar M.; Hassan A.S.; Awad H.M.; Mady M.F.; Design, synthesis and antitumor evaluation of novel pyrazolopyrimidines and pyrazoloquinazolines. Molecules 2018,23(6),1249","journal-title":"Molecules"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1080\/00397911.2017.1358368","volume":"47","author":"Hassan A.S.","year":"2017","unstructured":"Hassan A.S.; Moustafa G.O.; Awad H.M.; Synthesis and in vitro anticancer activity of pyrazolo[1,5-a]pyrimidines and pyrazolo[3,4-d][1,2,3]triazines. Synth Commun 2017,47(21),1963-1972","journal-title":"Synth Commun"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1021\/acs.jmedchem.9b00687","volume":"62","author":"Guo Y.","year":"2019","unstructured":"Guo Y.; Liu Y.; Hu N.; Yu D.; Zhou C.; Shi G.; Zhang B.; Wei M.; Liu J.; Luo L.; Tang Z.; Song H.; Guo Y.; Liu X.; Su D.; Zhang S.; Song X.; Zhou X.; Hong Y.; Chen S.; Cheng Z.; Young S.; Wei Q.; Wang H.; Wang Q.; Lv L.; Wang F.; Xu H.; Sun H.; Xing H.; Li N.; Zhang W.; Wang Z.; Liu G.; Sun Z.; Zhou D.; Li W.; Liu L.; Wang L.; Wang Z.; Discovery of zanubrutinib (BGB-3111), a novel, potent, and selective covalent inhibitor of bruton\u2019s tyrosine kinase. J Med Chem 2019,62(17),7923-7940","journal-title":"J Med Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1021\/acs.joc.8b01571","volume":"83","author":"Castillo J-C.","year":"2018","unstructured":"Castillo J-C.; Tigreros A.; Portilla J.; 3-Formylpyrazolo[1,5- a]pyrimidines as Key Intermediates for the Preparation of Functional Fluorophores. J Org Chem 2018,83(18),10887-10897","journal-title":"J Org Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.3390\/molecules24214009","volume":"24","author":"Alsaedi A.M.R.","year":"2019","unstructured":"Alsaedi A.M.R.; Farghaly T.A.; Shaaban M.R.; Synthesis and Antimicrobial Evaluation of Novel Pyrazolopyrimidines Incorporated with Mono- and Diphenylsulfonyl Groups. Molecules 2019,24(21),4009","journal-title":"Molecules"},{"key":"ref=135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.08.007","volume":"29","author":"Osuma A.T.","year":"2019","unstructured":"Osuma A.T.; Xu X.; Wang Z.; Van Camp J.A.; Freiberg G.M.; Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators. Bioorg Med Chem Lett 2019,29(19)","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5155\/eurjchem.11.1.68-79.1942","volume":"11","author":"Kaping S.","year":"2020","unstructured":"Kaping S.; Sunn M.; Singha L.I.; Vishwakarma J.N.; Ultrasound-assisted synthesis of pyrazolo[1,5-a]pyrimidine-antipyrine hybrids and their anti-inflammatory and anti-cancer activities. Eur J Chem 2020,11(1),68-79","journal-title":"Eur J Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"28483","DOI":"10.1039\/C7RA04336H","volume":"7","author":"Castillo J-C.","year":"2017","unstructured":"Castillo J-C.; Rosero H-A.; Portilla J.; Simple access toward 3-halo- and 3-nitro-pyrazolo[1,5-a]pyrimidines through a one-pot sequence. RSC Advances 2017,7,28483-28488","journal-title":"RSC Advances"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10593-019-02582-7","volume":"55","author":"Mehranpour A.","year":"2019","unstructured":"Mehranpour A.; Hashemnia S.; Bornak M.; Synthesis and characterization of new pyrido- and pyrazolopyrimidine derivatives using 2-substituted vinamidinium salts. Chem Heterocycl Compd 2019,55(11),1087-1091","journal-title":"Chem Heterocycl Compd"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1016\/j.bmcl.2004.08.046","volume":"14","author":"Compton D.R.","year":"2004","unstructured":"Compton D.R.; Carlson K.E.; Katzenellenbogen J.A.; Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: Defining the orientation of a novel heterocyclic core. Bioorg Med Chem Lett 2004,14(22),5681-5684","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/BF02976195","volume":"20","author":"Attaby F.A.","year":"1997","unstructured":"Attaby F.A.; Eldin S.M.; Reactions of 3-aminopyrazole derivatives with cyanothioacetamide and its derivatives: Synthesis and reactions of several new pyrazole and pyrazole[3,2-b]pyrimidine derivatives. Arch Pharm Res 1997,20(4),330-337","journal-title":"Arch Pharm Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1016\/j.tetlet.2007.07.041","volume":"48","author":"Quiroga J.","year":"2007","unstructured":"Quiroga J.; Portilla J.; Abonia R.; Insuasty B.; Nogueras M.; Cobo J.; Regioselective synthesis of novel polyfunctionally substituted pyrazolo[1,5-a]pyrimidines under solvent-free conditions. Tetrahedron Lett 2007,48,6352-6355","journal-title":"Tetrahedron Lett"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1016\/j.tetlet.2008.08.044","volume":"49","author":"Quiroga J.","year":"2008","unstructured":"Quiroga J.; Portilla J.; Abonia R.; Insuasty B.; Nogueras M.; Cobo J.; Regioselective synthesis of novel substituted pyrazolo[1,5-a]pyrimidines under solvent-free conditions. Tetrahedron Lett 2008,49,6254-6256","journal-title":"Tetrahedron Lett"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tetlet.2007.11.054","volume":"49","author":"Daniels R.N.","year":"2008","unstructured":"Daniels R.N.; Kim K.; Lebois E.P.; Muchalski H.; Hughes M.; Lindsley C.W.; Microwave-assisted protocols for the expedited synthesis of pyrazolo[1,5-a] and [3,4-d]pyrimidines. Tetrahedron Lett 2008,49,305-310","journal-title":"Tetrahedron Lett"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1021\/cc0700039","volume":"9","author":"Gregg B.T.","year":"2007","unstructured":"Gregg B.T.; Tymoshenko D.O.; Razzano D.A.; Johnson M.R.; Pyrazolo[1,5-a]pyrimidines. Identification of the privileged structure and combinatorial synthesis of 3-(hetero)arylpyrazolo[1,5-a]pyrimidine-6-carboxamides. J Comb Chem 2007,9(3),507-512","journal-title":"J Comb Chem"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/jm101452x","volume":"54","author":"Yoshida M.","year":"2011","unstructured":"Yoshida M.; Mori A.; Kotani E.; Oka M.; Makino H.; Fujita H.; Ban J.; Ikeda Y.; Kawamoto T.; Goto M.; Kimura H.; Baba A.; Yasuma T.; Discovery of novel and potent orally active calcium-sensing receptor antagonists that stimulate pulselike parathyroid hormone secretion: Synthesis and structure-activity relationships of tetrahydropyrazolopyrimidine derivatives. J Med Chem 2011,54(5),1430-1440","journal-title":"J Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s10593-012-1039-6","volume":"48","author":"Orlov V.D.","year":"2012","unstructured":"Orlov V.D.; Sidorenko D.Y.; Carbo[3\u2009+\u20093] cyclocondensation reactions. A new method for the synthesis of tetrahydropyrazolo[1,5-b]quinazolines and tetrahydropyrazolo[4,5-b]quinolines. Chem Heterocycl Compd 2012,48,650-657","journal-title":"Chem Heterocycl Compd"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"11268","DOI":"10.1021\/acs.joc.6b02217","volume":"81","author":"Golubev P.","year":"2016","unstructured":"Golubev P.; Karpova E.A.; Pankova A.S.; Sorokina M.; Kuznetsov M.A.; Regioselective synthesis of 7-(trimethylsilylethynyl)pyrazolo[1,5-a]pyrimidines via reaction of pyrazolamines with enynones. J Org Chem 2016,81(22),11268-11275","journal-title":"J Org Chem"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/slct.201702767","volume":"3","author":"Singsardar M.","year":"2018","unstructured":"Singsardar M.; Sarkar R.; Majhi K.; Sinha S.; Hajra A.; Br&#xF8;nsted acidic ionic liquid-catalyzed regioselective synthesis of pyrazolopyrimidines and their photophysical properties. ChemistrySelect 2018,3,1404-1410","journal-title":"ChemistrySelect"},{"key":"ref=149","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2019.108548","volume":"154","author":"Monier M.","year":"2020","unstructured":"Monier M.; El-Mekabaty A.; Abdel-Latif D.; Do&#x11F;ru Mert B.; Elattar K.M.; Heterocyclic steroids: Efficient routes for annulation of pentacyclic steroidal pyrimidines. Steroids 2020,154","journal-title":"Steroids"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jhet.4174","volume":"58","author":"Elattar K.M.","year":"2020","unstructured":"Elattar K.M.; El-Mekabaty A.; Heterocyclic steroids: Synthetic routes and biological characteristics of steroidal fused bicyclic pyrimidines. J Heterocycl Chem 2020,58(2),389-414","journal-title":"J Heterocycl Chem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1016\/j.tetlet.2014.04.011","volume":"55","author":"Kaishap P.P.","year":"2014","unstructured":"Kaishap P.P.; Baruah S.; Shekarrao K.; Gogoi S.; Boruah R.C.; A facile method for the synthesis of steroidal and nonsteroidal 5-methyl pyrazolo[1,5-a]pyrimidines. Tetrahedron Lett 2014,55,3117-3121","journal-title":"Tetrahedron Lett"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1021\/jm300164q","volume":"55","author":"Blad C.C.","year":"2012","unstructured":"Blad C.C.; van Veldhoven J.P.D.; Klopman C.; Wolfram D.R.; Brussee J.; Lane J.R.; Ijzerman A.P.; Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A). J Med Chem 2012,55(7),3563-3567","journal-title":"J Med Chem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1016\/j.bmcl.2008.08.039","volume":"18","author":"Shen H.C.","year":"2008","unstructured":"Shen H.C.; Taggart A.K.P.; Wilsie L.C.; Waters M.G.; Hammond M.L.; Tata J.R.; Colletti S.L.; Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A. Bioorg Med Chem Lett 2008,18(18),4948-4951","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1021\/acs.jmedchem.8b01266","volume":"62","author":"Childress E.S.","year":"2019","unstructured":"Childress E.S.; Wieting J.M.; Felts A.S.; Breiner M.M.; Long M.F.; Luscombe V.B.; Rodriguez A.L.; Cho H.P.; Blobaum A.L.; Niswender C.M.; Emmitte K.A.; Conn P.J.; Lindsley C.W.; Discovery of novel central nervous system penetrant metabotropic glutamate receptor subtype 2 (mGlu2) negative allosteric modulators (NAMs) based on functionalized pyrazolo[1,5- a]pyrimidine-5-carboxamide and thieno[3,2- b]pyridine-5-carboxamide Cores. J Med Chem 2019,62(1),378-384","journal-title":"J Med Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"14594","DOI":"10.1021\/acs.jmedchem.0c01246","volume":"63","author":"Quancard J.","year":"2020","unstructured":"Quancard J.; Simic O.; Pissot Soldermann C.; Aichholz R.; Blatter M.; Renatus M.; Erbel P.; Melkko S.; Endres R.; Sorge M.; Kieffer L.; Wagner T.; Beltz K.; Mcsheehy P.; Wartmann M.; R&#xE9;gnier C.H.; Calzascia T.; Radimerski T.; Bigaud M.; Weiss A.; Bornancin F.; Schlapbach A.; Optimization of the in vivo potency of pyrazolopyrimidine MALT1 protease inhibitors by reducing metabolism and increasing potency in whole blood. J Med Chem 2020,63(23),14594-14608","journal-title":"J Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/BF02317814","volume":"34","author":"Makarov V.A.","year":"1998","unstructured":"Makarov V.A.; Tafeenko V.A.; Granik V.G.; Synthesis of pyrazolo[1,5-a]pyrimidines by the reaction of dicarbonyl compounds with 3,5-diamino-4-nitropyrazole. Chem Heterocycl Compd 1998,34(12),1423-1427","journal-title":"Chem Heterocycl Compd"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF02256848","volume":"36","author":"Makarov V.A.","year":"2000","unstructured":"Makarov V.A.; Soloveva N.P.; Chernyshev V.V.; Sonneveld E.J.; Granik V.G.; Study of the reaction of 3,5-diamino-4-carbomethoxypyrazole with acetoacetic ester. synthesis of pyrazolo[1,5-a]pyrimidine. Chem Heterocycl Compd 2000,36(1),70-73","journal-title":"Chem Heterocycl Compd"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02256847","volume":"36","author":"Makarov V.A.","year":"2000","unstructured":"Makarov V.A.; Solov\u2019eva N.P.; Ryabova O.B.; Granik V.G.; Synthesis of pyrazolo[1,5-a]pyrimidines by reaction of 3,5-diamino-4-nitropyrazole with acetoacetic ester in the presence of alkaline agents. Chem Heterocycl Compd 2000,36(1),65-69","journal-title":"Chem Heterocycl Compd"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/jm00109a028","volume":"34","author":"Larsen S.D.","year":"1991","unstructured":"Larsen S.D.; Spilman C.H.; Bell F.P.; Dinh D.M.; Martinborough E.; Wilson G.J.; Synthesis and hypocholesterolemic activity of 6,7-dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, novel inhibitors of acylCoA:Cholesterol O-acyltransferase. J Med Chem 1991,34(5),1721-1727","journal-title":"J Med Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1021\/jm020999w","volume":"46","author":"Selleri S.","year":"2003","unstructured":"Selleri S.; Bruni F.; Costagli C.; Costanzo A.; Guerrini G.; Ciciani G.; Gratteri P.; Bonaccini C.; Malmberg Aiello P.; Besnard F.; Renard S.; Costa B.; Martini C.; Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands. J Med Chem 2003,46(2),310-313","journal-title":"J Med Chem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s10593-010-0583-1","volume":"46","author":"Danagulyan G.G.","year":"2010","unstructured":"Danagulyan G.G.; Boyakhchyan A.P.; Kirakosyan V.G.; An example of a domino reaction in the synthesis of pyrazolo[1,5-a]pyrimidine derivative. Chem Heterocycl Compd 2010,46(6),768-769","journal-title":"Chem Heterocycl Compd"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm1007566","volume":"53","author":"Wang X.","year":"2010","unstructured":"Wang X.; Berger D.M.; Salaski E.J.; Torres N.; Dutia M.; Hanna C.; Hu Y.; Levin J.I.; Powell D.; Wojciechowicz D.; Collins K.; Frommer E.; Lucas J.; Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity. J Med Chem 2010,53(21),7874-7878","journal-title":"J Med Chem"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1021\/jm400182t","volume":"56","author":"Aghazadeh Tabrizi M.","year":"2013","unstructured":"Aghazadeh Tabrizi M.; Baraldi P.G.; Saponaro G.; Moorman A.R.; Romagnoli R.; Preti D.; Baraldi S.; Ruggiero E.; Tintori C.; Tuccinardi T.; Vincenzi F.; Borea P.A.; Varani K.; Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. J Med Chem 2013,56(11),4482-4496","journal-title":"J Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10593-011-0760-x","volume":"47","author":"Danagulyan G.G.","year":"2011","unstructured":"Danagulyan G.G.; Boyakhchyan A.P.; Danagulyan A.G.; Panosyan H.A.; C\u2013C Recyclizations of some 2,7-disubstituted 6-ethoxycarbonylpyrazolo[1,5-a]pyrimidines. Chem Heterocycl Compd 2011,47(3),321-331","journal-title":"Chem Heterocycl Compd"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1134\/S107042801109017X","volume":"47","author":"Denislamova E.S.","year":"2011","unstructured":"Denislamova E.S.; Bubnov N.V.; Aliev Z.G.; Five-membered 2,3-dioxo heterocycles: LXXX. Recyclization of 1H-pyrrole-2,3-diones into pyrazolo[1,5-a]pyrimidines by the action of pyrazolamine. Crystalline and molecular structure of substituted pyrazolo[1,5-a]pyrimidine. Russ J Org Chem 2011,47,1362-1365","journal-title":"Russ J Org Chem"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1021\/acscombsci.8b00032","volume":"20","author":"Schmitt D.C.","year":"2018","unstructured":"Schmitt D.C.; Niljianskul N.; Sach N.W.; Trujillo J.I.; A Parallel Approach to 7-(Hetero)arylpyrazolo[1,5- a]pyrimidin-5-ones. ACS Comb Sci 2018,20(5),256-260","journal-title":"ACS Comb Sci"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1021\/jo800190v","volume":"73","author":"Sagar R.","year":"2008","unstructured":"Sagar R.; Park S.B.; Facile and efficient synthesis of carbohybrids as stereodivergent druglike small molecules. J Org Chem 2008,73(8),3270-3273","journal-title":"J Org Chem"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1080\/00397910600591763","volume":"36","author":"Bondock S.","year":"2006","unstructured":"Bondock S.; Khalifa W.; Fadda A.A.; Utility of 1\u2010chloro\u20103,4\u2010dihydronaphthalene\u20102\u2010carboxaldehyde in the synthesis of novel heterocycles with pharmaceutical interest. Synth Commun 2006,36(11),1601-1612","journal-title":"Synth Commun"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.tetlet.2006.02.031","volume":"47","author":"Kiselyov A.S.","year":"2006","unstructured":"Kiselyov A.S.; Smith L.; Novel one-pot synthesis of polysubstituted pyrazolo[1,5-a]-and imidazo[1,2-a]pyrimidines. Tetrahedron Lett 2006,47,2611-2614","journal-title":"Tetrahedron Lett"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/molecules24061080","volume":"24","author":"Fouda A.M.","year":"2019","unstructured":"Fouda A.M.; Abbas H.S.; Ahmed E.H.; Shati A.A.; Alfaifi M.Y.; Elbehairi S.E.I.; Synthesis, in vitro antimicrobial and cytotoxic activities of some new pyrazolo[1,5-a]pyrimidine derivatives. Molecules 2019,24(6),1080","journal-title":"Molecules"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1021\/acs.joc.6b00332","volume":"81","author":"Sun J.","year":"2016","unstructured":"Sun J.; Qiu J-K.; Jiang B.; Hao W-J.; Guo C.; Tu S-J.I.; I2-catalyzed multicomponent reactions for accessing densely functionalized pyrazolo[1,5-a]pyrimidines and their disulphenylated derivatives. J Org Chem 2016,81(8),3321-3328","journal-title":"J Org Chem"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/00397911.2017.1332224","volume":"47","author":"Ali T.E.","year":"2017","unstructured":"Ali T.E.; Ali M.M.; Abdel-Kariem S.M.; Ahmed M.M.; Reaction of 2-cyano[(4-oxo-4H-chromen-3-yl)methylidene]acetohydrazide with phosphorus reagents: Synthesis and evaluation of anticancer activities of some novel 1,2-azaphospholes, 1,2,3-diazaphospholidine, and 1,3,2-diaza-phosphinanes bearing a chromone ring. Synth Commun 2017,47(16),1458-1470","journal-title":"Synth Commun"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1021\/jm201386u","volume":"55","author":"Finlay H.J.","year":"2012","unstructured":"Finlay H.J.; Lloyd J.; Vaccaro W.; Kover A.; Yan L.; Bhave G.; Prol J.; Huynh T.; Bhandaru R.; Caringal Y.; DiMarco J.; Gan J.; Harper T.; Huang C.; Conder M.L.; Sun H.; Levesque P.; Blanar M.; Atwal K.; Wexler R.; Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitor. J Med Chem 2012,55(7),3036-3048","journal-title":"J Med Chem"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bmcl.2015.01.003","volume":"25","author":"Kannan M.","year":"2015","unstructured":"Kannan M.; Raichurkar A.V.; Khan F.R.N.; Iyer P.S.; Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents. Bioorg Med Chem Lett 2015,25(5),1100-1103","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/acsomega.6b00417","volume":"2","author":"Reddy Kotla S.K.","year":"2017","unstructured":"Reddy Kotla S.K.; Vandavasi J.K.; Wang J-J.; Parang K.; Tiwari R.K.; Palladium-catalyzed intramolecular cross-dehydrogenative coupling: synthesis of fused imidazo[1,2-a]pyrimidines and pyrazolo[1,5-a]pyrimidines. ACS Omega 2017,2(1),11-19","journal-title":"ACS Omega"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"15347","DOI":"10.1021\/acs.joc.8b02606","volume":"83","author":"Hoang G.L.","year":"2018","unstructured":"Hoang G.L.; Streit A.D.; Ellman J.A.; Three-Component Coupling of Aldehydes, Aminopyrazoles, and Sulfoxonium Ylides via Rhodium(III)-Catalyzed Imidoyl C-H Activation: Synthesis of Pyrazolo[1,5- a]pyrimidines. J Org Chem 2018,83(24),15347-15360","journal-title":"J Org Chem"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11030-019-09976-x","volume":"24","author":"Alizadeh-Kouzehrash M.","year":"2020","unstructured":"Alizadeh-Kouzehrash M.; Rahmati A.; A four-component reaction: Regio- and chemoselective formation of 7-amino-2-(tert-butyl)-5-aryl-4,5-dihydropyrazolo[1,5-a]pyrimidine-6-carbonitrile. Mol Divers 2020,24(3),753-761","journal-title":"Mol Divers"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jhet.5570350112","volume":"35","author":"Quiroga J.","year":"1998","unstructured":"Quiroga J.; Hormaza A.; Insuasty B.; Saitz C.; Ca&#xF1;ete A.; Jullian C.; Synthesis of pyrazolo[1,5\u2010a]pyrimidines in the reaction of 5\u2010amino\u20103\u2010arylpyrazoles with methoxymethylene meldrum\u2019s acid derivatives and thermolysis of their pyrazolylaminomethylene derivatives. J Heterocycl Chem 1998,35(1),61-64","journal-title":"J Heterocycl Chem"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1021\/jo070265x","volume":"72","author":"Pinho e Melo T.M.","year":"2007","unstructured":"Pinho e Melo T.M.; Nunes C.M.; Soares M.I.L.; Paix&#xE3;o J.A.; Beja A.M.; Silva M.R.; Chemistry of diazafulvenium methides in the synthesis of functionalized pyrazoles. J Org Chem 2007,72(12),4406-4415","journal-title":"J Org Chem"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1021\/jm201524g","volume":"55","author":"Yeh V.S.C.","year":"2012","unstructured":"Yeh V.S.C.; Beno D.W.A.; Brodjian S.; Brune M.E.; Cullen S.C.; Dayton B.D.; Dhaon M.K.; Falls H.D.; Gao J.; Grihalde N.; Hajduk P.; Hansen T.M.; Judd A.S.; King A.J.; Klix R.C.; Larson K.J.; Lau Y.Y.; Marsh K.C.; Mittelstadt S.W.; Plata D.; Rozema M.J.; Segreti J.A.; Stoner E.J.; Voorbach M.J.; Wang X.; Xin X.; Zhao G.; Collins C.A.; Cox B.F.; Reilly R.M.; Kym P.R.; Souers A.J.; Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:Diacylglycerol acyltransferase 1. J Med Chem 2012,55(4),1751-1757","journal-title":"J Med Chem"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"10090","DOI":"10.1021\/jm3012239","volume":"55","author":"Hanan E.J.","year":"2012","unstructured":"Hanan E.J.; van Abbema A.; Barrett K.; Blair W.S.; Blaney J.; Chang C.; Eigenbrot C.; Flynn S.; Gibbons P.; Hurley C.A.; Kenny J.R.; Kulagowski J.; Lee L.; Magnuson S.R.; Morris C.; Murray J.; Pastor R.M.; Rawson T.; Siu M.; Ultsch M.; Zhou A.; Sampath D.; Lyssikatos J.P.; Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitors. J Med Chem 2012,55(22),10090-10107","journal-title":"J Med Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"12364","DOI":"10.1021\/acs.joc.6b02431","volume":"81","author":"Castillo J-C.","year":"2016","unstructured":"Castillo J-C.; Estupi&#xF1;an D.; Nogueras M.; Cobo J.; Portilla J.; 6-(Aryldiazenyl)pyrazolo[1,5-a]pyrimidines as Strategic Intermediates for the Synthesis of Pyrazolo[5,1-b]purines. J Org Chem 2016,81(24),12364-12373","journal-title":"J Org Chem"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1021\/acs.jafc.9b07449","volume":"68","author":"Zhang Y-Y.","year":"2020","unstructured":"Zhang Y-Y.; Gao S.; Liu Y-X.; Wang C.; Jiang W.; Zhao L-X.; Fu Y.; Ye F.; Design, synthesis, and biological activity of novel diazabicyclo derivatives as safeners. J Agric Food Chem 2020,68(11),3403-3414","journal-title":"J Agric Food Chem"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1002\/pola.22848","volume":"46","author":"Coluccini C.","year":"2008","unstructured":"Coluccini C.; Metrangolo P.; Parachini M.; Pasini D.; Resnati G.; Righetti P.; &#x201C;Push-pull&#x201D; supramolecular chromophores supported on cyclopolymers. J Polym Sci A Polym Chem 2008,46(15),5202-5213","journal-title":"J Polym Sci A Polym Chem"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1039\/C4OB02643H","volume":"13","author":"Caricato M.","year":"2015","unstructured":"Caricato M.; Delforge A.; Bonifazi D.; Dondi D.; Mazzanti A.; Pasini D.; Chiral nanostructuring of multivalent macrocycles in solution and on surfaces. Org Biomol Chem 2015,13(12),3593-3601","journal-title":"Org Biomol Chem"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1039\/c004379f","volume":"8","author":"Caricato M.","year":"2010","unstructured":"Caricato M.; Coluccini C.; Dondi D.; Vander Griend D.A.; Pasini D.; Nesting complexation of C60 with large, rigid D2 symmetrical macrocycles. Org Biomol Chem 2010,8(14),3272-3280","journal-title":"Org Biomol Chem"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1021\/cm0104304","volume":"13","author":"Pasini D.","year":"2001","unstructured":"Pasini D.; Klopp J.M.; Fr&#xE9;chet J.M.J.; Design, synthesis, and characterization of carbon-rich cyclopolymers for 193 nm microlithography. Chem Mater 2001,13(11),4136-4146","journal-title":"Chem Mater"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1021\/jacs.7b03412","volume":"139","author":"Nitti A.","year":"2017","unstructured":"Nitti A.; Bianchi G.; Po R.; Swager T.M.; Pasini D.; Domino direct arylation and cross-aldol for rapid construction of extended polycyclic &#x3C0;-scaffolds. J Am Chem Soc 2017,139(26),8788-8791","journal-title":"J Am Chem Soc"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"10550","DOI":"10.1021\/acs.jafc.0c01867","volume":"68","author":"Guo K-L.","year":"2020","unstructured":"Guo K-L.; Zhao L-X.; Wang Z-W.; Gao Y-C.; Li J-J.; Gao S.; Fu Y.; Ye F.; Design, synthesis, and bioevaluation of substituted phenyl isoxazole analogues as herbicide safeners. J Agric Food Chem 2020,68(39),10550-10559","journal-title":"J Agric Food Chem"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/ps.6193","volume":"77","author":"Wang Z-W.","year":"2020","unstructured":"Wang Z-W.; Zhao L-X.; Ma P.; Ye T.; Fu Y.; Ye F.; Fragments recombination, design, synthesis, safener activity and CoMFA model of novel substituted dichloroacetylphenyl sulfonamide derivatives. Pest Manag Sci 2020,77(4),1724-1738","journal-title":"Pest Manag Sci"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1021\/acs.jafc.0c04436","volume":"69","author":"Kang T.","year":"2021","unstructured":"Kang T.; Gao S.; Zhao L-X.; Zhai Y.; Ye F.; Fu Y.; Design, synthesis, and SAR of novel 1,3-disubstituted imidazolidine or hexahydropyrimidine derivatives as herbicide safeners. J Agric Food Chem 2021,69(1),45-54","journal-title":"J Agric Food Chem"}],"container-title":["Current Organic Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/193269","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/193269\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/193269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T20:32:58Z","timestamp":1672086778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/193269\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":195,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570179418666210509015108","relation":{},"ISSN":["1570-1794"],"issn-type":[{"type":"print","value":"1570-1794"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}